Compliance is the pre-requisite and the overarching principle of all activities of Boehringer Ingelheim, its management and its employees. It maintains our license to operate and also protects our trustful and reliable business relations with our customers and business partners.
Special emphasis is placed on the following topics:
- Bribery and Corruption
- Anti-competitive practices
- Insider trading
- Improper export and trade transactions
- Breach of Data Privacy Laws
- Inappropriate transactions with healthcare professionals, healthcare organizations, patient organizations or public officials in the healthcare sector
- Violations of our Code of Conduct.
It might happen that you as a Boehringer Ingelheim employee, customer, external party, or in any other relation to Boehringer Ingelheim, become aware of an action or behavior which is, or could be assumed to be, not in line with our commitment, such as wrongdoing, misbehavior, doubtful practices, or deviation from policies and procedures. In this case we encourage you to “speak up” and report this to us.
As we appreciate open communication, we encourage you to provide us with your name and contact details, which will also support the efficient and effective conduct of any investigation we might perform based on your report. Your name and report will be treated confidentially and shared only on a need-to-know basis or as required by local legislation.
Reporting directly to line manager or to Compliance Officer
We encourage our employees to report their concern directly to somebody within their direct working environment, e.g. their line manager, the local Boehringer Ingelheim Compliance Officer, the HR department or any other Boehringer Ingelheim manager of their trust.
Boehringer Ingelheim has committed in its “Speak Up” policy that reports made in good faith, i.e. based on the belief that what you are asserting is true (whether or not a subsequent investigation process can confirm the assertion), shall not result in retaliation.